Detalles de la búsqueda
1.
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.
Eur J Nucl Med Mol Imaging
; 50(10): 3137-3146, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37261472
2.
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
World J Urol
; 41(9): 2343-2350, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515651
3.
Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy.
Eur J Nucl Med Mol Imaging
; 45(4): 602-612, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29185010
4.
Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy.
BJU Int
; 119(1): 30-37, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27037533
5.
A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer.
Prostate
; 76(13): 1160-8, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27198487
6.
Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer.
J Urol
; 196(2): 382-91, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26964917
7.
Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy.
Urol Int
; 96(1): 51-6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26513586
8.
Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients.
BMC Cancer
; 15: 458, 2015 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26051431
9.
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 41(4): 694-701, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24297503
10.
Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.
Eur Radiol
; 24(8): 1821-6, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24889997
11.
Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy.
Urol Int
; 93(2): 207-13, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25012094
12.
Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen-targeted Salvage Surgery.
Eur Urol Oncol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729805
13.
Prostate-specific Membrane Antigen-radioguided Surgery Facilitates Pelvic Lymph Node Dissection During Radical Prostatectomy for the Treatment of Locally Advanced Prostate Cancer with Regional Lymph Node Metastases.
Eur Urol Oncol
; 6(1): 95-98, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36604297
14.
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer.
Cancers (Basel)
; 15(20)2023 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894375
15.
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T.
J Nucl Med
; 64(11): 1765-1771, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37678925
16.
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery.
Eur Urol
; 83(1): 62-69, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35718637
17.
Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer.
BJU Int
; 110(11 Pt B): E635-40, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22889368
18.
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography.
Eur Urol
; 82(2): 156-160, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34887117
19.
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment.
PLoS One
; 17(6): e0269827, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35700180
20.
Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer.
Transl Androl Urol
; 10(10): 3963-3971, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804839